Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lin, Juntang  [Clear All Filters]
2019
Du, J., Ji, Y., Qiao, L., Liu, Y., and Lin, J. (2019). Cellular endo-lysosomal dysfunction in the pathogenesis of non-alcoholic fatty liver disease.Liver Int.
Liu, Q., Du, J., Fan, J., Li, W., Guo, W., Feng, H., and Lin, J. (2019). Generation and Characterization of Induced Pluripotent Stem Cells from Mononuclear Cells in Schizophrenic Patients.Cell J21, 161-168.
Yang, C., Li, X., Zhang, B., Fu, S., Li, S., Shen, J., Guan, L., Qiao, L., and Lin, J. (2019). The Mechanism of Rap1 Regulates N-cadherin to Control Neuronal Migration.J Mol Neurosci.
Liu, Y., Niu, R., Li, W., Lin, J., Stamm, C., Steinhoff, G., and Ma, N. (2019). Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases.Cell Mol Life Sci.
2018
Zhu, X., Liu, Y., Yu, J., Du, J., Guo, R., Feng, Y., Zhong, G., Jiang, Y., and Lin, J. (2018). LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signaling.Atherosclerosis281, 38-46.
Zhu, X., Du, J., Yu, J., Guo, R., Feng, Y., Qiao, L., Xu, Z., Yang, F., Gong, G., Liu, F., et al. (2018). LncRNA NKILA regulates endothelium inflammation by controlling a NF-κB/KLF4 positive feedback loop.J Mol Cell Cardiol.
2016
Chen, H., Nan, W.B., Wei, X., Wang, Y., Lv, F., Tang, H., Li, Y., Zhou, C., Lin, J., Zhu, W., et al. (2016). Toxicity, pharmacokinetics, and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy.Artif Cells Nanomed Biotechnol1-8.